The impact of the withdrawal of Adderall XR (long-acting mixed amphetamine salts) from the Canadian market on paediatric patients and their families. [electronic resource]
Producer: 20111110Description: 373-8 p. digitalISSN:- 1205-7088
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.